Germany· DE-A57-5d49105ca7ad63de
Solifenacin/Tamsulosin Stada
A medicinal product containing tamsulosin hydrochloride, solifenacin succinate, registered in Germany by Stadapharm Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Tamsulosin Hydrochloride, Solifenacin Succinate
- Manufacturer
- Stadapharm Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tamsulosin hydrochloride, solifenacin succinate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- NetherlandsJomil 6 mg/0,4 mg, tabletten met gereguleerde afgifteHeaton k.s.
- SpainBITAMSOL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGLaboratorios Q Pharma S.L.
- United KingdomSolifenacin 6mg / Tamsulosin 400microgram modified-release tabletsA A H Pharmaceuticals Ltd
- PolandBeplasot+pharma arzneimittel GmbH
- IrelandSolifenacin succinate/Tamsulosin hydrochloride Clonmel 6 mg/0.4 mg modified-release tabletsClonmel Healthcare Ltd
- NorwaySolifenacin/Tamsulosin NewburyNewbury Pharmaceuticals AB
- FinlandSolifenacin/Tamsulosin STADASTADA Arzneimittel AG
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Solicomp, Solifenacin/Tamsulosin Stada
- Belgium · Solifenacine / Tamsulosine Eurogenerics, Solifenacine/Tamsulosine
- Bulgaria · Везира, Везомни
- Cyprus · Nefilin
- Czechia · Beplasot, Jomil
- Denmark · Solifenacin/Tamsulosin Adalvo, Solifenacin/Tamsulosin Newbury
- Estonia · Solitombo
- Spain · Blobax, Daital
- Finland · Solifenacin/Tamsulosin Stada, Urizia
- France · Vecalmys
- United Kingdom (Northern Ireland) · Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science, Solifenacin Succinate/Tamsulosin Hydrochloride Altair Science Limited
- Greece · Desoltam, Nefilin
- Croatia · Beplasot, Semquest
- Hungary · Mingerlan, Örgunderin
- Ireland · Solifenacin Succinate/Tamsulosin, Solifenacin Succinate/Tamsulosin Hydrochloride Clonmel
- Iceland · Soltamcin
- Italy · Luracin, Solifenacina E Tamsulosin Mylan
- Lithuania · Solitombo
- Luxembourg · Solifenacine/Tamsulosine, Solifenacine/Tamsulosine Eurogenerics
- Malta · Jomil
- Netherlands · Jomil, Mingerlan
- Norway · Solifenacin/Tamsulosin Newbury, Solifenacin/Tamsulosin Stada
- Poland · Beplasot, Mingerlan
- Portugal · Blatan, Solifenacina + Tansulosina Generis
- Romania · Mingerlan, Solifenacin/Tamsulosin Gemax Pharma
- Sweden · Urizia
- Slovenia · Semquest, Solifenacin/Tamsulozin Belupo
- Slovakia · Jomil, Solifenacín/Tamsulozín Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf3cbe5c-985c-4d24-b7c1-e1a3143390e6 GET /v1/drugs/cf3cbe5c-985c-4d24-b7c1-e1a3143390e6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Tamsulosin Hydrochloride, Solifenacin Succinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about tamsulosin hydrochloride, solifenacin succinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.